Pfizer Inc. said on Sept. 16 the company was recalling all lots of the anti-smoking treatment Chantix due to high levels of cancer-causing agents called nitrosamines in the pills.

The U.S. Food and Drug Administration said on Sept. 9 the regulatory agency needs more time to decide whether e-cigarette maker Juul Labs Inc. and other major manufacturers can sell their products in the United States.

More than 55 million people worldwide are living with dementia, a neurological disorder that robs them of their memory and costs the world $1.3 trillion a year, the World Health Organization (WHO) said on Sept. 2.

Pfizer Inc. said on Aug. 13 the company is recalling four additional lots of the anti-smoking treatment Chantix after finding elevated levels of cancer-causing agents called nitrosamines in the pills.

Pfizer issued a voluntary recall for 12 lots of the company’s anti-smoking drug Chantix (varenicline) due to the presence of a nitrosamine impurity exceeding the company’s established Acceptable Daily Intake (ADI) level. As a result, Pfizer is pausing distribution of Chantix and is accelerating the company’s internal testing of the product.

The U.S. drug regulator said on July 16 the FDA will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc. halted distribution of the company’s Chantix branded varenicline.

Shares of U.K.-based Vectura Group were up more than 13% in trading after Philip Morris International announced the tobacco giant’s plans to acquire the company for $1.44 billion in cash.

Fewer Americans are dying from the most common types of cancer, especially lung, showed a report published in The Journal of the National Cancer Institute on July 8.

Pfizer Inc. is pausing distribution of the company’s anti-smoking treatment, Chantix, after finding elevated levels of cancer-causing agents called nitrosamines in the pills.

FCB New York and the U.S. FDA announced that they have launched the newest evolution of “The Real Cost” youth tobacco prevention campaign.